Christmas‐Related Reduction in Beta Activity in Parkinson's Disease
Background Subthalamic nucleus (STN) beta (13 ‐ 35 Hz) activity is a biomarker reflecting motor state in Parkinson's disease (PD). Adaptive deep brain stimulation (DBS) aims to use beta activity for therapeutic adjustments, but many aspects of beta activity in real‐life situations are unknown....
Saved in:
Published in | Movement disorders Vol. 38; no. 4; pp. 692 - 697 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.04.2023
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Subthalamic nucleus (STN) beta (13 ‐ 35 Hz) activity is a biomarker reflecting motor state in Parkinson's disease (PD). Adaptive deep brain stimulation (DBS) aims to use beta activity for therapeutic adjustments, but many aspects of beta activity in real‐life situations are unknown.
Objective
The aim was to investigate Christmas‐related influences on beta activity in PD.
Methods
Differences in Christmas Day to nonfestive daily averages in chronic biomarker recordings in 4 PD patients with a sensing‐enabled STN DBS implant were retrospectively analyzed. Sweet‐spot and whole‐brain network connectomic analyses were performed.
Results
Beta activity was significantly reduced on Christmas Eve in all patients (4.00–9.00 p.m.: −12.30 ± 10.78%, P = 0.015). A sweet spot in the dorsolateral STN connected recording sites to motor, premotor, and supplementary motor cortices.
Conclusions
We demonstrate that festive events can reduce beta biomarker activity. We conclude that circadian and holiday‐related changes should be considered when tailoring adaptive DBS algorithms to patient demands. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
April Infographic: Christmas‐Related Reduction in Beta Activity in Parkinson's Disease |
---|---|
Bibliography: | A.A.K. declares that she is on the advisory board of Medtronic and Boston Scientific and has received honoraria from Medtronic, Boston Scientific, and Teva. G.‐H.S., R.L., L.K.F., J.R., and W.‐J.N. received honoraria for talks from Medtronic; there are no other relationships or activities that could appear to have influenced the submitted work. Relevant conflicts of interest/financial disclosures Funding agencies This study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—Project ID 4247788381—TRR 295 Grant and the Lundbeck Foundation Grant (no.: R336‐2020‐1035). L.K.F. and R.L. are fellows of the BIH Charité (Junior) Clinician Scientist Program. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0885-3185 1531-8257 |
DOI: | 10.1002/mds.29334 |